Top Markets
Coin of the day
Metagenomi, Inc. Common Stock Metagenomi, Inc. Common Stock

Metagenomi, Inc. Common Stock

MGX
Rankning i aktier #25865
Metagenomi, Inc. operates as a biotechnology company focused on gene editing,... Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Aktiekurs
$1.21
Senast synkroniserad: 2026-08-20
Marknadsvärde
$45.55M
Förändring (1 dag)
-2.43%
Förändring (1 år)
-34.60%
Land
US
Handel Metagenomi, Inc. Common Stock (MGX)

Kategori

Aktiekurshistorik för Metagenomi, Inc. Common Stock (MGX)
Högsta slutkurs: $1.22 den 2026-08-01

Lägsta slutkurs: $11.71 den 2024-02-01
Aktiekurshistorik för Metagenomi, Inc. Common Stock från 2024 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -2.20%
2025 -48.40%
2024 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US